Updates are available Correction dated 2022-01-27

Article History

Received: 28 February 2021

Accepted: 4 November 2021

First Online: 18 November 2021

Change Date: 27 January 2022

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1186/s12885-022-09226-8

Declarations

:

: The TH3RESA trial obtained independent ethical approval for the conduct of the study and subsequent use of anonymised data for research purposes from the institutional review boards covering 146 study sites in 22 countries. All patients provided written informed consent. TH3RESA was conducted in accordance with the Declaration of Helsinki, Good Clinical Practice guidelines, and applicable local laws. The data were made available for use in this study by F. Hoffman La Roche and were used under license. Data were fully anonymised, non-identifiable and accessed according to Roche’s policy and process for clinical study data sharing.

: Not applicable. Data is anonymised.

: The authors have no competing interests.